Crossmark

Spironolactone, a therapeutic alternative in the treatment of diffuse retinal pigment epitheliopathy

Crossref DOI link: https://doi.org/10.1016/j.oftale.2016.05.005

Published Print: 2016-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ángel-Pereira, D.

Rocha-Cabrera, P.

Cordovés-Dorta, L.

Losada Castillo, M.J.

Blasco Alberto, A.

Abreu Reyes, J.A.
License Information

Text and Data Mining valid from 2016-12-01
More Information

This article is maintained by: Elsevier

Article Title: Spironolactone, a therapeutic alternative in the treatment of diffuse retinal pigment epitheliopathy

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2016.05.005

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2016.02.007

Content Type: article

Copyright: © 2016 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.